Stats

Ran node /app/agent/dist/backtest.js --symbols AVO --strategy momentum --lookback20 --days730.500bars,24trades. Premise1 genericmomentumdoesnotestimateadatedearningsedge.2 CLIreturnnegative,noindependentCLIholdout. Conclusionnegativecrosscheckonly; chronologicalvectorbteventtestseparatelyrecordedgoverns. https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=AVO . Do not usebuyholdoutperformanceasrunupprobability.

Premises1 primary23earningsJan2021–Jun2026 from67SEC8Ks,actualearningssentences recorded;Dec19 2024excludedbecauseNov5preannouncement https://www.sec.gov/Archives/edgar/data/1802974/000180297424000046/avo-20241105.htm .2 Frozenbeforeoutcomes note1015,train2021–24N16/holdout2025–26N6,T1previoussessionopen-close;vectorbtlongonly,10bpfee+10bpslippage eachside;independentcompounding matches.3 Baseline train-15.6021%,holdout-7.3318%,DD9.372%,p50%,W1.31844%,L3.74363%,mean-1.21259%,95%bootstrapmeanCI[-3.75774,1.05684]%.1ATRstop/1.5ATRtargetconservativestopfirst:train-20.4866%,holdout-4.01016%,DD6.12344%,p50%,W1.31844%,L2.62743%,mean-.654495%.4 All16holdoutvariants(h0/1/3/5,time/barrier,slip10/25bp)lose. h0same-dateconditionaldiagnostic-5.51296%time/-9.55199%barrierN6,p0; firstreleaseAMCnotverifiedhistorically so notvalidtradablestrategy. CONCLUSION reject,size0; Sep8cannotborrowSep4prior-sessionwindow. Validitynecessaryedgefails; soundnesslimitsarchivaladvance-noticesmissing,shortselectedcohort,adjusteddailyOHLCnot15minfills,May28Calavostructuralbreakonlyonepostcloseevent. No assumptionofknownhistoricaldatesbeforeactualnotice. Statisticalnegativitysufficestostopcostlyarchive/fillresearch; notproofallrunupslose. Market https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=AVO&timeframe=1Day&feed=sip&adjustment=all . 100kbootstrapseed2026090808,reproresearch/test.py.

START49.14fundcash/850.99equity,flat/noqueue; GOALrepeatablepre-eventbasehits; BINDINGconstraintvalidatednetedgeandactualentrywindow. Premises1 primarydatesconfirmedLOVE Sep10beforeopen https://investor.lovesac.com/news-events/press-releases/detail/166/the-lovesac-company-announces-second-quarter-conference ; SFIXSep23afterclose https://investors.stitchfix.com/news-events/press-releases/news-details/2026/Stitch-Fix-Announces-Date-for-Fourth-Quarter-and-Full-Fiscal-Year-2026-Financial-Results-and-Conference-Call/default.aspx .2 LOVE1086 T5holdout+19.24%N7butCI[-1.05,6.14]%; testedentryalreadyelapsed.3 SFIX1087train-36.40%N20 andhistoricalnoticenotverified; coststressholdoutCIcrosses0.4 Indicators1090 cannotrescueconfidence, currentscenarioreward/risk1.27/1.29<1.5; simulation1097five-sessionmean-.0368%/-1.4850%.5 Fundamental1104supersedes1098arithmetic; recurringcashqualityisnotrunupprobability. CONCLUSION noPROPOSE/EXIT/ADJUST/FUND; adoptedsize0. Validity: necessarygatesfailsoentryrejected; soundnesslimitedbysmallselectedissuercohorts,lookaheadinSFIXdateavailability,dailybarfillmodel,unknownactualfees/earlynewshazard. Strongcounterargumentpositiveholdoutandliquiditysuggestpossibleopportunity; neitherfixestraining/uncertainty norvalidateslateentry. Evidenceforrevision: prospectivelyfrozennotice-awareeventcohortwithpositivecostrobustmeanCI,actual15minexits,propercurrentwindow; no refitfromonegoodreport. Questiontree961 completedatdecisionresolution; SFIXnoticearchive/15minfillstoppedafterfailednecessarygates, gapsnamed. Monitoring80preserves17plusnewissuers,existing75deliveryverified; 20monitorscap leavesnewreviewsunarmed andcollectorremindersonly. Research/records~17minuteswithin45max; finalrecordphasebegan06:14:43,finishby06:19:43. Noordersrequiredwhileflat,next08UTCcheckcollectoractualdelivery.

Ran node /app/agent/dist/backtest.js --symbols SFIX --strategy momentum --lookback 20 --days 730;500bars. Premise1 genericmomentumdiagnosticisnotthedated-eventrule. Premise2 negativeCLIreturnandnoindependentCLIholdout cannotvalidateallocation. Conclusionuseonlyasnegativecrosscheck; costedchronologicalvectorbteventstudies1086–1087areprimary. Source https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=SFIX

Ran node /app/agent/dist/backtest.js --symbols LOVE --strategy momentum --lookback 20 --days 730;500bars. Premise1 genericmomentumdiagnosticisnotthedated-eventrule. Premise2 negativeCLIreturnandnoindependentCLIholdout cannotvalidateallocation. Conclusionuseonlyasnegativecrosscheck; costedchronologicalvectorbteventstudies1086–1087areprimary. Source https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=LOVE

This replaces1098 prose arithmetic, retainingitsvalidprimaryinputs. Premises1 LOVEJune11 issuer https://investor.lovesac.com/news-events/press-releases/detail/164/the-lovesac-company-reports-first-quarter-fiscal-2027 : Q1GM52.1%,productmargin+330bp-inbound/tariff380bp-outbound110bp=-160bp. Q2EBITDAguide-4to+2m midpoint-1m includes3.6mrefundexpectedrecognizedQ2; illustrative fullrefundexclusion gives-4.6m, notmanagementguidance. FYEBITDAmid40.5m/salesmid720m=5.625% (NOT5.79%); netincomemid8.5m. May3shares14.63855m timesSep4price16.69 =244.3173995m proxycap/8.5m=28.7432x earnings. Mixedvintages andforwardguide makeitasensitivity,notcurrentEVorprecisevaluation.2 SFIXJune10 https://investors.stitchfix.com/news-events/press-releases/news-details/2026/Stitch-Fix-Announces-Third-Quarter-of-Fiscal-2026-Financial-Results/default.aspx : adjustedEBITDA13.239m-SBC11.139m=2.100m beforeotherGAAPadjustments,notGAAPnetincome; Q3FCF6.520mvs15.998m=-59.2449%,repurchase15.1m exceedsFCF8.580m. Clientgrowth+.9%sequential/-1.9%YoYconsistent;52weekactiveaccountsnotuniquepeople.3 Lowcashdebtcanallowinvestmentbutdoesnotidentifypriceedge. Conclusionwatchrecurringcash; neitherrefundrecognitionnoradjustedprofitjustifiesrun-upallocation.

Facts: https://investor.lovesac.com/news-events/press-releases/detail/164/the-lovesac-company-reports-first-quarter-fiscal-2027 and https://investors.stitchfix.com/news-events/press-releases/news-details/2026/Stitch-Fix-Announces-Third-Quarter-of-Fiscal-2026-Financial-Results/default.aspx . Premise1 bothhaveverifiedupcomingearningsbutoperatingqualityandpriceedgeareseparate. Conditionalpositivechain1 actualclient/comps andretainedmarginimprove;2 inventoryandmarketingcostconvertgrowthtoincrementalcash;3 reducedexternalfundingneed/moreproductivecapitalreturns maybenefitshareholders. Conditionalnegativechain1 promotions/costpressureorweakretention erodemargins;2 inventory/fulfillmentcostabsorboperatingcash;3 buybacksgreaterthanFCFornewcapitalneeds reducefutureflexibility. LOVEcustomersmaybenefitfromlowerdeliverycosts,domesticmanufacturersfrompaidorders; SFIXclients/stylistsfrombetterretention,adplatformsfromspend,employeesfromSBC; noautomaticequitybenefit. Countercaseweakerpricealreadydiscountsrisks,positiveearningscouldrallystrongly; truebuttestsfailcertainty/currentwindow. Third-order narratives neitherestimatewinprobabilitynorauthorizeholdingthroughresults. FactsendatJunequarter/source,date; futurecashandrepricingareconditional.

Premises1 LOVEJune11 direct https://investor.lovesac.com/news-events/press-releases/detail/164/the-lovesac-company-reports-first-quarter-fiscal-2027 Q1sales138.196m,comps-1%,GM52.1%,cash56.998m,noLOCdraw. Productmargin+330bp vs inbound/tariff-380bp andoutbound-110bp yields-160bp; actualcostsoutweighproductimprovement. Q2guideadjEBITDA-4to+2m includes3.6mcollectedrefund expectedrecognizedQ2: midpoint-1m minus3.6m gives-4.6m illustrative recurringadjustment, contingent on fullrecognitiontreatment; notissueradjustedguide. FYEBITDA35–46m is5.79%of720m atmidpoint, notnetmargin.2 SFIXJune10 https://investors.stitchfix.com/news-events/press-releases/news-details/2026/Stitch-Fix-Announces-Third-Quarter-of-Fiscal-2026-Financial-Results/default.aspx Q3rev340.277m+4.7%;clients2.309m+.9%QoQ/-1.9%YoY canbothbetrue;52weekmetricnotuniquepeople. EBITDA13.239m minusSBC11.139m=2.100m,beforeD&A/interest,notGAAPprofit;Q3FCF6.520m falls59.245%YoY,repurchases15.1m exceedFCFby8.58m;netcashhelpsfundbutnotvalidateallocation.3 LOVEproxyordinaryequity16.69*14.63855m=244.3174m,~24.94xmidpointFYnetincome9.8? CORRECTION midpoint(5+12)/2=8.5m,28.743x; sharecountMay3 andpriceSep4differentdates, roughscenario notcurrentEV. SFIXvaluationnotclaimedwithoutcurrentactualoutstandings. Conclusion watchorganiccash/definitions; nofundamentalnumberconvertsinto pre-eventwinprobability.

Premises1 100000seededpaths resample complete trainingT5eventreturns,20trades perpath,fund49.14,exposurefractions0/.25/.5/1. Sources https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=LOVE,SFIX&timeframe=1Day&feed=sip&adjustment=all .2 LOVEtrainingN16 fullfractionmedian90.576 after20trades,P20%drawdown25.353%; SFIXN20 median30.968,P20%drawdown96.414%,Ploss93.981%. These20quarterlyevents are NOT20days or monthend forecasts; empiricalresamplingignoresparameteruncertainty/unseenjumps, no asset-priceforecast.3 Separately normalize completefive-sessiontraining OHLCblocks toSep4entry, priorcurrentATRstop1x/target1.5x,conservativebarriers/costs: LOVE16blockswin43.652%,stop56.348%,target43.652%,mean-.03678%,p5-4.3688%,p95+5.5552%;SFIX20blockswin29.825%,stop70.175%,mean-1.4850%,p5-4.6678%,p95+6.0037%. Allpathsmetbarrierunderthesehistoricalblocks,notproofrealtradesmustexit.4 NetRR1.272/1.286<1.5; LOVEhorizon5unavailabletoday. Conclusion adopt0,notpositivehistoricalKelly. ReportedmechanicalquarterKelly usesbinarywin/lossriskfraction,notnotional; exactfractionallog-growth sizing requiresjointpayoff/gapmodel andfailedvalidationpreventsallocation. No earlyearningsnewshazardor15minfilllikelihood estimated.30%gapfullfund14.742>8.5099riskbudget.

Premises1 combinepriorclose>SMA50 AND20sessionmomentum>0, keepfixedT5barrierreturns. https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=LOVE,SFIX,SPY&timeframe=1Day&feed=sip&adjustment=all .2 LOVEjointtrue trainingN5mean1.582%CI[-5.236,8.102]%, holdoutN0: zero rows mean UNAVAILABLE, not0% expectedreturn; JSONzero placeholdersnotobservedperformance. JointfalseholdoutN7samebaselineuncertainty.3 SFIXjointtrue trainN6mean.548%CI[-4.575,6.023]%,holdoutN4mean4.691%CI[-2.112,9.068]%; no independentfilteredge.4 BothcurrentjointfalsewhileSPYabove200; markettrendcannotoverrideissuertrend/date/netedge failures. Indicatorcorrelation/dayautocorr descriptiveLOVEcorrSPY.409/autocorr.0251,SFIX.386/- .0340; no causalallocation. Conclusion no optimizedfilter adopted; allfourfactorstwo-statecellsrecorded.

Premises1 SIPalladjusted1930bars each, finalSep4 complete; noSep7NYSEholidaybar expected. https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=LOVE,SFIX,SPY&timeframe=1Day&feed=sip&adjustment=all .2 LOVE16.69<SMA50 16.9538,momentum20-6.341%,ATR14.66518,average20dayrange.62807,vol39.17%,medianvolume159846,range15.18–18.02. SFIX3.05<SMA50 3.6872,momentum-27.381%,ATR.130714,range.15275,vol48.20%,medianvolume1370821,range3–4.115.3 Atstaleclose1ATRstop/1.5ATRtargetLOVE16.0248/17.6878 netRR1.272;SFIX2.9193/3.2461 netRR1.286 after20bpperside. Thesearescenariosnotorders/quotes. Wholeaffordability2LOVEor16SFIX beforecosts; actualquarterKellyunknown. Conclusion no currentpositivejointtrend/netRRgate; donotstretch targettoforce1.5. Costsassumednotbrokerfeeverification; price/volumeplausibilitydoesnotprovefill.

Premises1 frozenT5barrier eventreturns in recordedobservations; sources https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=LOVE,SFIX,SPY&timeframe=1Day&feed=sip&adjustment=all .2 OLS(intercept,priorSMA50flag,momentum20flag,SPY200flag,vol20) LOVEtrainN16R2.162,holdoutN7R2.681 butonly2residualdegreesfreedom; SFIXtrainN20R2.526,holdoutN10R2.080 andrank4becauseSPYtrendconstant. No regression forecast or causal claim.3 Equal-yearbootstrapLOVEholdoutCI[.072,6.579]%lookspositivebutestimatesdifferentweightedmeanfrom7eventCI[-1.048,6.139]% andresamplesonly3years; no substitutionforfailedgate.4 LeaveoneoutLOVEmeans1.883–4.113%holdout; SFIXtrainingallnegative-2.676to-1.669%; exclude2020trainingmeansLOVE3.525%,SFIX-1.839%. Wholemarketmisses: only2freshissuersselectedbeforepriceinspection; repeatedissuerquartersdependent,crossnamesnotindependentmacroshock. Priorunvalidated; wouldchangeonlywithpreregisteredprospectivecalendar,matchedcohort,netmeanuncertaintyabove0andactualexecutioncheck. Censoredlive3losses provide no averagewin; don'tpoolbiotechwithretail.

Premises1 34actualearningssentences identified in70SEC8Ks,30with2019–26bars; do notusecoverdate. Example https://www.sec.gov/Archives/edgar/data/1576942/000162828026042186/sfix-20260610.htm .2 Historical ADVANCE NOTICE times unverified: this is retrospective/oracle-date diagnostic, notdeployablecalendarbacktest.3 FrozenT5open toT1close beforeeventdate,fees10bp+slippage10bp eachside,priorATR14 stop1ATR,target1.5ATR,conservativebarriers,vectorbtlongonly/openclosemarks andindependentcompounding.4 Training2019–23 loses36.40%N20,p35%,W6.178%,L6.461%; holdout2024–26 gains45.56%N10,p70%,W7.732%,L4.689%. BaseholdoutmeanCI[.0076,7.4546]% becomes[-.2030,7.1197]% with25bpslippage. Timeonlytrain-48.00%,holdout+24.99%CIcrosses0.9/12holdoutvariantspositive; none rescuesfailedtraining/datedesign. ConclusionrejectSep16T5entry; no retuningholdout. https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=SFIX&timeframe=1Day&feed=sip&adjustment=all . IPOsurvivorselection,UKclosureandchangedregimeslimittransfer; dailyexitsnot15minvalidation.

Premises1 issuer historical notices paired to32actual releases;33rd upcoming https://investor.lovesac.com/news-events/press-releases . Bars1930daily2019Jan2–2026Sep4 https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=LOVE&timeframe=1Day&feed=sip&adjustment=all .2 Frozen note961 T5open toT1close, train2019–23,holdout2024–26. Fees10bp/slippage10bp each side; ATR14frompriorclose stop1ATR,target1.5ATR, samebarstopfirst,gapstopatopen,targetcapped; vectorbt cashonly longonly, independentcompoundingreconciled.3 Exclude2018withoutbars,2020Apr16afterJan13guidance,Nov3/Dec6 2023preliminaryQ2/Q3; notice>=entrydate excluded withouttiming.4 Finaltrain+62.16%,N16,meanCI[-.262,6.616]%; holdout+19.24%,N7,CI[-1.048,6.139]%. Stress25bpslippageholdout+16.76%,CI[-1.318,5.821]%. Timeonlyholdout23.33%,CI[-.061,6.385]%. All12variantsrecorded,10positiveholdouts; no winnerselection. Conclusion insufficientcertainty/actualwindowpassed; cannottransferT5toSep8two-sessionentry. CashDD marks open/close only, excludesunseenintradayexcursions; fillsnotvenue15minvalidated. Exclusionaudit lowersinitialtraining118.73%N17 to62.16%N16; notindependentlychosenuniversesample.

START49.14USDfundcash/850.99equity/0holdingsandqueued(context); GOALrepeatablepre-eventbasehits; BINDINGconstraintvalidatedexecutableedge. Premises1 latestSep3/4sponsorconfirmsSep28FDAdate https://www.egetis.com/mfn_news/egetis-therapeutics-to-participate-in-upcoming-investor-conferences-in-september/ ; deadlineisnotfirstnewstime.2 ClinicaltotalitycredibleforperipheralbenefitbutSAPchronology/finalsurvivaldatasetunresolved (927), noapprovalorpriceprobability.3 Cash/voucherbridge934conditional,notfreeupside.4 Preregisteredgenerictrend931 train-87.65%,holdout-51.03%N56,all18holdoutvariantsnegative; notFDAeventbacktest.5 NetRR1.17/freshness/foreignvenuefail932–933. CONCLUSIONnoPROPOSE/EXIT/ADJUST/FUND; adoptedquarterKelly0. Validity: failednecessarygatesentailcash; soundnessboundedbydailybarrierapproximation,unverifiedforeigncosts,selectionandmissingeventcohort. Counterargumentapproval/USlaunchcoulddriveasubstantialrally; truebutcannotquantifynetbefore-eventedge. Tochangeprior: independentlyregisteredcostrobusteventholdoutmeanCIabovezero,executablevenueandgapexits; onefavorableannouncementinsufficient. Questiontree915completedtodecisionresolution; sourcesstoppedchangingdecisionafterlatestconferenceabstractrepeatedsameReTRIACtresults andSep4noticeconfirmedalreadypublisheddata. Missingfinalsurvival/SAP/manufacturingreview/privatepayerprices explicitlygaps,notnegativefacts. Fullsourceclaims/derivedfiguresrecorded,nomediaheadlineactedon. Job75registered480min72runs replacingtested72; 20monitorcaprejectleavesEGTXstaticremindersunarmed. Noordersneededwhileflat; next06UTCverifyjob75actualdelivery. Finalrecordphase04:09–~04:11UTC; ~10minelapsed of45max,unusedbudgetnotneeded.

Premises1 exactSep28datepassedissuerverification https://www.egetis.com/mfn_news/egetis-therapeutics-to-participate-in-upcoming-investor-conferences-in-september/ ; firstdecisionminuteunconfirmed.2 Price>SMA50and20rowmomentumpositive (obs12356) passdescriptivejointtrend; freshnessfailsSep7OHLCmissing.3 Ruleoutofsample56tradesnegativeand18/18variantsnegative (analysis931).4 RangebasedcostedRR1.17<1.5 (932).5 CLI0foreignbars,venue/FXfeesunverified.6 Earlybinarynotboundedbystop (933). Conclusion overallentryFALSE; no weightedscorecancompensateforanecessarygatefailure. StrongcounterargumentcurrentpreFDAregimediffersfromhistoricaltrend; true,whichrequiresnewindependentvalidation ratherthangenericbacktesttransfer. Facts endatdateddisclosures/pricedata; FDAoutcome/USsales/runupdemandremainassumptions.

Directquery fund=catalyst Sep8 https://runway.adityaperswal.workers.dev (runway:query_trades?fund=catalyst). Exactprice/qty3losses total-31.9373USD,mean-16.3806%; MIRM/IONSoperatorliquidationcensorplannedexits. RAREloss6.440Rusingentry25.84/originalstop24 andexit13.98976; noclaimpreciseorderslippagewithoutcontemporaneousquotes. Zeroobservedwinsdoesnotprovepopulationp=0; nowinningtradesmeansaveragewinunidentified. EGTXindependentgenerictrendholdoutN56,p.375,W7.383%,L6.091% -> negativeKellyclipped0; cannotpoolwithFDAtrades. Priceone-dayautocorr.0460descriptiveonly. Survivalcohort228/484=47.107%retained; selectedoldercohortHR.28 cannotbeconvertedtoFDAapprovalodds (https://www.endocrine-abstracts.org/ea/0101/ea0101op-03-04). Premises mismatch/censoring/negativeexpectancypreventcalibration; conclusionsize0. Evidencebarforchange: anindependentdated-eventholdoutpositiveaftercostswithmeanuncertaintyabovezero plusvenue/gapvalidation; notasinglerally.

Factsanchored https://www.egetis.com/mfn_news/egetis-therapeutics-to-participate-in-upcoming-investor-conferences-in-september/ ; vouchertermsobs12330 https://attachment.news.eu.nasdaq.com/aa8bae6e3da62b95404c23eb6ec2cc25a . Conditionalbull:1FDAauthorizationopenspaidUSaccess/possiblevoucher;2 payercoverage/distributionandmonetizationconvertopportunitytocash;3 reducedfutureequityneedmaybenefitcommonholders. Conditionalbear:1delay/CRLpushescashreceiptsout;2 preparatoryspendcontinuesorcutsslowlaunch;3 refinancing/dilutioncantransferupsideawayfromexistingholders. Whobenefits: patientsfromeffectivecare,distributionpartnersfrompaidvolume,RTTsellersfromcontractualvouchershare,investorsfromresidualcash; noneguaranteed. Eventstructure: publicabstractsalreadyprecedepresentations,soSep8posterisnotcleanfirstreadout; firsttworegulatorybranchescanoccurbeforeSep28deadline. Thirdorderpossibilitydoesnotassignstockprobability. Countercaseapprovalandprofitablelaunchcouldoutweighallfrictions; needobservedprice/netpayoffevidence,notnarrativeordering.

Derivedfromobs12330 https://attachment.news.eu.nasdaq.com/aa8bae6e3da62b95404c23eb6ec2cc25a andstaleSep4price https://query1.finance.yahoo.com/v8/finance/chart/EGTX.ST . CashdividedbyQ2operating+investingburn gives11.75months fromJun30; includingQ2debt/leaserate10.78months, notmanagementrunwayguidance. Samecostquarterimplies273.1MSEK afterQ3; actualcosts/receivables/discounts/launchmaydiffer. Ordinarysharegrowth17.66% year-to-Jun30; raise fee5.4%; ordinaryequity3.580bnSEK/~51.44xannualizedQ2sales69.6MSEK, neitherEVnorforwardrevenuevaluation. NoSEKUSDconversionimputed. Assumedvoucher netsales100/150/200MUSD yields50/75/100 retainedbeforeunmodeledtax/timing; thisiscontingentscenario,notsalequote. Premises: positivecashmostlyfinancing,launchvaluealreadyrequiredbyhighcurrentsalesmultiple,benefitsharesplit. Conclusionnotnear-termcashcrisisatflatburn,notfreevoucherarbitrage; strongestbullfutureUSsales+voucher couldtransformcashbutwecannotpriceapprovalorpre-eventdrift. ConfidentialUSnetprice/payeruptakeandfinalsurvivalpackage gaps preventDCFfalseprecision.

Python numpy seed20260908 followingbacktests; training836dailyOHLCvectors normalizedtopriorclose, iidresample10sessions/100000paths from https://query1.finance.yahoo.com/v8/finance/chart/EGTX.ST . Start7.70,stop7.34429,target8.23357; gapstopopen,stoppriorityifboth,takeprofittarget,otherwisecloseafter10. Fees10bp/slip25bp/side. Mean-1.21410%,win37.666%,p05-5.69831%,p95+6.18361%,stops62.245%,targets37.570%,time.185%. Thesearehistoricalvolatilityresampling,NOTFDAprobabilities; iidpathscanmissclusters/novelbinarytails and15minexecution. SeparateassumedUSDlossstress for49.14fund:30%gap14.742,50%gap24.57, both>8.5099riskcap; attheseassumedshocksriskboundnotionals28.3663/17.0198 BEFOREcosts,notrecommendedsizes. Full-lossbound8.5099. Bindingedgefailssoadoptednotional0 regardlessstresscapacity; noestimatedregulatorywinprobability.

Premises1 research dailychart https://query1.finance.yahoo.com/v8/finance/chart/EGTX.ST endsSep4 despitemetadataSep7price7.65; noSep7OHLC inthisresponse.2 Lastcomplete7.70>SMA50 6.751 and20row+8.757%, but theseindicators' jointentryfailsbacktest.3 ATR14.355714,20rowmeanrange.318 givescandidate stop7.34429,target8.23357:target1.678averagedailyranges but slightlyabove20rowhigh8.20. NetRR1.170 atmodeledcosts, below1.5minimum.4 medianvolume678731.5 indicateshistoricalactivity, not currentdepth/executability. Conclusion noorder/pricelevelrecommendation. Couldtightenstop/raisetargettomakeratiofit, butwouldalterpreregisteredrule orbreakrangeconstraint; rejectinstead. Worsthistoricaladjustedovernight-26.8382% May24 2023 reinforcesgaprisk withoutprovingFDAshockfrequency. Return/volatilitywindows areobservedrows notcalendardays.

Frozen note921 before computation. Yahoo adjustedOHLC https://query1.finance.yahoo.com/v8/finance/chart/EGTX.ST ; trainingSep2021–Dec2024,holdoutJan2025–Sep4 2026. Priorclose>SMA50 and20rowreturn>0 entersnextopen; prior14row simpleATR sets1ATRstop/1.5ATRtarget; exitwithin10sessions, no samebarreentry. Gapstopfillsopen; targets capped; bothbarriersstopfirst. Fees10bp+slippage25bp eachside; stress50bpslippage. vectorbt direction=longonly, two timestamp slots/day permit same-day exit; compoundedtrade/portfolio returns reconciled1e-8. Close-markedDD approximate, no15minpath, FX/minimumforeigncommissionexcluded. Train-87.6467%,DD91.0246%,N89,win33.7079%. Holdout figures below; 10000iidtradebootstrapmeanCI[-2.77568,.80464]%; regime dependence weakensCI. Sweep SMA30/50/70,hold5/10/15,two costs:18holdoutvariants ALLnegative[-75.9915,-43.2968]%; no selectionadopted. Premises actualtestedlongtrendloses; USFDAhistoricalcohortabsent andvenueCLI0bars. Conclusionrejectthisrule; cannotinferallFDAstrategieslose orborrow generictrendwins fordatedtrade. Fullreproduction research/test.py,results/trades files saved locally and journalchunks forthcoming.

Premises1 EMA independent assessment supports peripheral-thyrotoxicosis indication (https://www.ema.europa.eu/en/medicines/human/EPAR/emcitate).2 ReTRIACt biochemical endpoint positive but rescue endpoint negative, neurological trialnegative; differentendpoints makebothpartlyright, not contradiction (obs12332–34).3 Currentregistry https://clinicaltrials.gov/api/v2/studies/NCT05579327 has completionbefore sponsor-describedSAPrevision; historicalSAP/unblindingnotobtained, so prospectivehierarchyunresolved.4 Survivalabstract https://www.endocrine-abstracts.org/ea/0101/ea0101op-03-04 has selection/residencyimbalance andauthorsflagconfounding/immortaltime; laterN>600notindependentlyaudited. CONCLUSION clinicalbenefitplausible, but neither approvalprobability norpre-eventreturnquantifiablefromthese data. Validity: uncertainfinancialedgecannotfollowfromclinicalp-value. Soundnesslimitedversions/missingpatientdata. Strongcounterargument: rare-disease totality plusEUauthorization mayjustifyFDAapproval despitefailedendpoints; agreed,therefore notbearishapprovalprediction. Prior broadbiochemicalbenefitconfidence strengthened; tradeprobabilityremainsunidentified. Tochange allocationneedcostrobustindependentactual-window eventcohort plus executablevenue; positiveFDAdecisionalone comesafterrunupwindow.

START all49.14Catalystcash,850.99equity,0holdings/queued(context); GOAL repeatablepre-eventbasehits; BINDING constraint independentlyvalidated feasible netedge,notcapitalshortfall. Premises1 own3losses/2operatorcensored providesnoallocatableedge (851).2 NewPLAY dateSep14 https://ir.daveandbusters.com/news-releases/news-release-details/dave-busters-entertainment-inc-report-second-quarter-2026 leavesfourregularsessions; fixedtest848 train-13.155%,holdout+6.879%N6butmeanCI[-4.485,7.251]%,stop/targetnetRR1.382<1.5(849),genericMonteCarlomean-.0615%(850).3 Fundamental adjustedFCF25.3mincludes16.8massetfinancing,organic8.5m; actualQ2turnaroundunknown (834).4 Othernewprimarydates haveuntestedpayoffs/foreigneligibility; CANbeforeopenhasnoregularrunup; cryptoissuertransmissionunproved (854/855). CONCLUSION noPROPOSE/EXIT/ADJUST/FUND,adoptedquarterKelly0. Validity: failednecessarygatesentailcash; soundness limitedselectedcohort,missinghistoricaladvancenotices,15minfills,venue429,YahoostalenessandforeignFX. StrongcounterargumentPLAYholdout2/3winsandcoststressstillpositive mayrally; notenoughtooverridenegativetraining/wideinterval. Wouldchangeprioronlywithindependentpositivecostrobustactual-windowedge andfreshquotes/gapmodel,notonegoodrealization. Newcalendarcoverage206US/391foreignisdiscovery,notexhaustiveprimarycensus;NASDAQAPI23timeouts,paginationunread. Existing20monitorsretained,newPLAYmonitorcaprejected; registeredjob72preserves30checks+PLAYRSS andstaticglobalreviews,notexactreviewexecution. Othercollectorscover02:30GRALand03:15IONS/MIRM/GIS before04UTCrun. Noordersorpublicsocialmessagesfrommanager. Finishrecordphasebegan02:11UTC,within43planned/45hard; remainingresearchbudgetnotneeded.

ResearchYahoocharts https://query1.finance.yahoo.com/v8/finance/chart/EGTX.ST , /ABVX,/4431.T,/0513.HK,/BTC-USD,/ETH-USD,/SOL-USD (fullURLsobs10133–45). ExcludedongoingSep8bars. EGTXlastvalidSep4SEK7.70aboveSMA50 6.751,20row+8.757%;SmaregiSep7JPY3485above3169.76,+8.906%;ABVXSep4USD114.79below125.153,-12.327%. 0513.HKSep7HKD.13above.1148,+8.333%,butdateunverified. CryptoSep7barabsent,latestcompleteavailableSep6,raw20rowreturnsBTC24.562/ETH31.500/SOL40.166% andSMA50 allbelowclose; stalehistorynotcurrenttape. Premises: trendaloneisdescriptive; exactdate/venueandneteventpayoffgatesfailindependently; conclusionnosignaladoption. Ratesare20observedrows,notassumed20calendardays; foreignFXanddifferentholidaysprecludenaiveranking. Countercasemomentumcouldcontinuethroughcalendar,requiresseparatecostedactualwindowtest; cannotborrowunrelatedcryptofundedge. No positive payoff probability assigned.